Clinical Trial Update: Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of asenapine in schizophrenia, compared with placebo and olanzapine; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Saphris (asenapine)
• Zyprexa (olanzapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED